An2 Therapeutics, Inc

Vifor Pharma is a global leader in iron deficiency and nephrology, dedicated to improving the lives of patients with severe and chronic diseases. With a strong presence worldwide, they strive to provide innovative therapies and solutions for those suffering from chronic kidney disease. Committed to transparency and patient well-being, Vifor Pharma conducts investigator-initiated studies and offers a range of nephrology products to address the specific needs of patients. Their mission is to help individuals lead better, healthier lives by providing effective treatments and support for chronic conditions.Generated from the website

Ascendis Pharma Inc., headquartered in Palo Alto, California, is a biopharmaceutical company focused on developing innovative therapies through its proprietary TransCon technology. The company's pipeline includes treatments in endocrinology and oncology aimed at improving patient outcomes worldwide. With operations across both Europe and the United States, Ascendis Pharma is committed to advancing medical science and enhancing the lives of patients through its ongoing clinical trials and product development initiatives. The firm's dedication to corporate responsibility and patient-centered care underscores its mission to make a meaningful impact in the healthcare landscape. Generated from the website

Founded in 1997, ChemoCentryx is a clinical-based pharmaceutical company that discovers and develops orally-administered small molecule therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. It has developed EnabaLink, which is a drug recovery technology that is designed to accelerate productive drug recovery program. The company also conducts preclinical evaluation of a series of anticancer compounds that target the CXCR7 chemokine receptor. ChemoCentryx evaluates a series of compounds that target the C5a chemo-attractant receptor to treat age-related macular degeneration, rheumatoid arthritis and systemic lupus erythematosus and other disorders. It has entered into a strategic alliance with Glaxo Group, which is an affiliate of GlaxoSmithKline. ChemoCentryx maintains its headquarters in Mountain View, Calif.